Cargando…

Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality

BACKGROUND: We contrasted impacts on all-cause and cardiovascular disease (CVD) mortality of diabetes vs. CVD. METHODS: Among participants the Tehran lipid and glucose study aged ≥ 30 years (n = 9752), we selected those who participated in the follow-up study until 20 March 2009 (n = 8795). Complete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bozorgmanesh, Mohammadreza, Hadaegh, Farzad, Sheikholeslami, Farhad, Ghanbarian, Arash, Azizi, Fereidoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461411/ https://www.ncbi.nlm.nih.gov/pubmed/22704235 http://dx.doi.org/10.1186/1475-2840-11-69

Ejemplares similares

No Obesity Paradox—BMI Incapable of Adequately Capturing the Relation of Obesity with All-Cause Mortality: An Inception Diabetes Cohort Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2014)

Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2016)

Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study
por: Mohammadreza, Bozorgmanesh, et al.
Publicado: (2012)

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
por: Hadaegh, Farzad, et al.
Publicado: (2010)

Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2011)

Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Beta-Cell Age Calculator, a Translational Yardstick to Communicate Diabetes Risk with Patients: Tehran Lipid and Glucose Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2012)

Associations of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: A long term follow-up study
por: Ramezankhani, Azra, et al.
Publicado: (2019)

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2022)

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2020)

Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up
por: Zafari, Neda, et al.
Publicado: (2017)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Khalili, Davood, et al.
Publicado: (2018)

The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study
por: Khalili, Davood, et al.
Publicado: (2014)

"Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?"
por: Hadaegh, Farzad, et al.
Publicado: (2011)

Stata Modules for Calculating Novel Predictive Performance Indices for Logistic Models
por: Barkhordari, Mahnaz, et al.
Publicado: (2016)

The Impact of Physical Activity on Non-communicable Diseases: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Sheikholeslami, Sara, et al.
Publicado: (2018)

Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study
por: Deravi, Niloofar, et al.
Publicado: (2022)

Survival Regression Modeling Strategies in CVD Prediction
por: Barkhordari, Mahnaz, et al.
Publicado: (2016)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population
por: Hadaegh, Farzad, et al.
Publicado: (2015)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study
por: Ramezankhani, Azra, et al.
Publicado: (2022)

Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study
por: Hashemi, Ashkan, et al.
Publicado: (2018)

Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study
por: Ramezankhani, Azra, et al.
Publicado: (2023)

The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study
por: Hosseinpanah, Farhad, et al.
Publicado: (2020)

Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study
por: Kheirandish, Masoumeh, et al.
Publicado: (2014)

Number of parity/live birth(s) and cardiovascular disease among Iranian women and men: results of over 15 years of follow-up
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2020)

The Effect of Community-Based Education for Lifestyle Intervention on The Prevalence of Metabolic Syndrome and Its Components: Tehran Lipid and Glucose Study
por: Azizi, Fereidoun, et al.
Publicado: (2013)

Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population
por: Ghasemzadeh, Zahra, et al.
Publicado: (2016)

Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-up
por: Masrouri, Soroush, et al.
Publicado: (2022)

Change in blood pressure status defined by 2017 ACC/AHA hypertension guideline and risk of cardiovascular disease: results of over a decade of follow-up of the Iranian population
por: Kabootari, Maryam, et al.
Publicado: (2023)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vgqefs14h2vncoaj76o3vgb5c1